P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19

NCT04410510 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

COVID
Coronavirus Infection
SARS-CoV 2
COVID19

Interventions

DRUG: P2Et (Caesalpinia spinosa extract)
OTHER: Placebo

Sponsor

Hospital Universitario San Ignacio

Collaborators

[object Object]